Literature DB >> 1673519

Tumour necrosis factor, interleukin-6, and malaria.

M E Molyneux, T E Taylor, J J Wirima, G E Grau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1673519     DOI： 10.1016/0140-6736(91)91745-g

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Authors:  R Harpaz; R Edelman; S S Wasserman; M M Levine; J R Davis; M B Sztein
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria.

Authors:  J L Sarthou; G Angel; G Aribot; C Rogier; A Dieye; A Toure Balde; B Diatta; P Seignot; C Roussilhon
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Up-regulation of cytokines in glomerulonephritis associated with murine malaria infection.

Authors:  R Sinniah; L Rui-Mei; A Kara
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

4.  Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines.

Authors:  P Ringwald; F Peyron; J P Lepers; P Rabarison; C Rakotomalala; M Razanamparany; M Rabodonirina; J Roux; J Le Bras
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

5.  Intravenous immunoglobulin in the treatment of paediatric cerebral malaria.

Authors:  T E Taylor; M E Molyneux; J J Wirima; A Borgstein; J D Goldring; M Hommel
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

6.  Severe malaria in African adults living in a seasonal endemic area.

Authors:  J M Saïssy; M Vitris; B Diatta; J Kempf; F Adam; J L Sarthou
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

Review 7.  Malaria: modification of the red blood cell and consequences in the human host.

Authors:  Christopher A Moxon; George E Grau; Alister G Craig
Journal:  Br J Haematol       Date:  2011-05-28       Impact factor: 6.998

8.  Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.

Authors:  Diana Quelhas; Laura Puyol; Llorenç Quintó; Tacilta Nhampossa; Elisa Serra-Casas; Eusébio Macete; Pedro Aide; Sergi Sanz; John J Aponte; Denise L Doolan; Pedro L Alonso; Clara Menéndez; Carlota Dobaño
Journal:  BMC Immunol       Date:  2012-01-26       Impact factor: 3.615

9.  Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.

Authors:  Deirdre Larkin; Bas de Laat; P Vince Jenkins; James Bunn; Alister G Craig; Virginie Terraube; Roger J S Preston; Cynthia Donkor; George E Grau; Jan A van Mourik; James S O'Donnell
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

10.  Inflammatory cytokine and humoral responses to Plasmodium falciparum glycosylphosphatidylinositols correlates with malaria immunity and pathogenesis.

Authors:  Babacar Mbengue; Birahim Niang; Maguette Sylla Niang; Marie Louise Varela; Becaye Fall; Mouhamadou Mansour Fall; Rokhaya Ndiaye Diallo; Bacary Diatta; D Channe Gowda; Alioune Dieye; Ronald Perraut
Journal:  Immun Inflamm Dis       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.